Correlation Between Singular Genomics and Merit Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Singular Genomics and Merit Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Singular Genomics and Merit Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Singular Genomics Systems and Merit Medical Systems, you can compare the effects of market volatilities on Singular Genomics and Merit Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Singular Genomics with a short position of Merit Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Singular Genomics and Merit Medical.

Diversification Opportunities for Singular Genomics and Merit Medical

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Singular and Merit is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Singular Genomics Systems and Merit Medical Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merit Medical Systems and Singular Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Singular Genomics Systems are associated (or correlated) with Merit Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merit Medical Systems has no effect on the direction of Singular Genomics i.e., Singular Genomics and Merit Medical go up and down completely randomly.

Pair Corralation between Singular Genomics and Merit Medical

Given the investment horizon of 90 days Singular Genomics is expected to generate 1.33 times less return on investment than Merit Medical. In addition to that, Singular Genomics is 5.09 times more volatile than Merit Medical Systems. It trades about 0.01 of its total potential returns per unit of risk. Merit Medical Systems is currently generating about 0.05 per unit of volatility. If you would invest  7,245  in Merit Medical Systems on August 30, 2024 and sell it today you would earn a total of  3,121  from holding Merit Medical Systems or generate 43.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Singular Genomics Systems  vs.  Merit Medical Systems

 Performance 
       Timeline  
Singular Genomics Systems 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Singular Genomics Systems are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain forward indicators, Singular Genomics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Merit Medical Systems 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Merit Medical Systems are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, Merit Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Singular Genomics and Merit Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Singular Genomics and Merit Medical

The main advantage of trading using opposite Singular Genomics and Merit Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Singular Genomics position performs unexpectedly, Merit Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merit Medical will offset losses from the drop in Merit Medical's long position.
The idea behind Singular Genomics Systems and Merit Medical Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing